EPISODE · Jan 31, 2025 · 21 MIN
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 22 Clinical Trial Design Nuances for Cannabinoid Therapies
from Cannabinoid and Psychedelic Pharmacology and Drug Development
This podcast episode explores the complexities and challenges of clinical trials for cannabinoid therapies. The discussion covers key aspects including:- Dosing variability and product consistency challenges in plant-derived compounds- Patient compliance and addressing stigma around cannabis research- Placebo control difficulties unique to cannabinoid studies- Special considerations for vulnerable populations like children and pregnant womenThe episode also examines promising therapeutic applications including chronic pain management, multiple sclerosis treatment, and potential cancer-related applications.
NOW PLAYING
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 22 Clinical Trial Design Nuances for Cannabinoid Therapies
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.